-
Experts concerned that HIV, AIDS may be poised for a comeback
"Current trends in HIV drug resistance are very concerning," said Dr. Chris Beyrer, lead author of an overview on the state of global HIV drug resistance. "Resistance levels have been found to be highest in ART-exposed infants and children," he added. "Which is a real concern, since children are already among the least-treated age group in many developing countries."
- Categories
- Health Care
-
Gates Foundation and PATH wire up health data in Africa using a novel approach
The partnership is digitizing and connecting Tanzania’s healthcare system, linking a fragmented array of databases and information sources. A unified system could dramatically improve efficiency, accountability and cost savings for a country of 45 million people that struggles with infectious diseases including HIV/AIDS.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Exclusive: Documents reveal largest USAID health project in trouble
Between Jan. 1 and March 31, 2017, only 7 percent of the health commodity shipments delivered through the GHSC-PSM project arrived at their destination “on time and in full” — a common metric for measuring the performance of a supply chain.
- Categories
- Health Care
-
‘Uncomfortable and disgusting’: Uganda’s 1.2m unwanted condoms
The government has spent hundreds of thousands of dollars on female prophylactics, but poor take-up is sparking concerns of a rise in HIV infections.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows
Although the cost of antiretroviral treatment has fallen dramatically since generic manufacturers first began to manufacture versions of antiretroviral drugs in India in 2001, generic products have not been available in all countries due to patent restrictions.
- Categories
- Health Care, Investing
-
Experimental HIV vaccine regimen is well-tolerated, elicits immune responses
Results from an early-stage clinical trial called APPROACH show that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against HIV in healthy adults.
- Categories
- Health Care
- Tags
- healthcare, HIV/AIDS, vaccines
-
Surviving a Pandemic: How ‘Economic Training’ Helps Families Live Beyond HIV/AIDS
Millions of households are struggling to support children affected by HIV/AIDS. A new approach seeks to ease their burden by integrating economic strengthening activities into programs that already serve orphans and vulnerable children and their extended families. It involves training practitioners with new skill sets, so they in turn can help others develop financial independence and resilience.
- Categories
- Health Care
-
Viewpoint: The Future Of Investment In PEPFAR: Understanding PEPFAR’s Multiple Economic, Health, And Diplomatic Impacts
There is much concern about the future of the President’s Emergency Plan for AIDS Relief, or PEPFAR, under the new administration. Since the creation of PEPFAR in 2003, the US has been the global leader in responding to the urgent need for the treatment and prevention of HIV/AIDS, and the care of orphaned and vulnerable children affected by the disease. With bipartisan support in Congress, PEPFAR was initiated under the Bush administration and continued under the Obama administration.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Parent Organization
